Tumor growth of the human U87 glioblastoma cells as xenografts on nude mice is delayed by treatment with monoclonal antibodies against human YKL-40 [197], suggesting that YKL-40 may be a potential cancer target. Here, CHI3L1 is linked to glioblastoma.